NCT00091806View on ClinicalTrials.gov

Two Dose Schedules of Panitumumab in Subjects With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

86

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

October 31, 2006

Conditions

TumorsOncologySolid Tumors

Interventions

DRUG

panitumumab (ABX-EGF)

6 mg/kg once every 2 weeks

DRUG

Panitumumab

9 mg/kg once every 3 weeks

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Amgen

INDUSTRY